It has been reported that the IGF-1/PI3K/Akt signaling pathway reduces denervation-, unloading-, and joint immobilization-induced muscle atrophy, and that the injection or overexpression of IGF-1 counteracts denervation- and age-related muscle atrophy (Timmer et al., 2018). The gene discussed is IGF1; the disease is muscle atrophy.